May Health’s Post

What are the Most Active VC Funds in Health-Tech in Europe? 💊 Despite shifts in funding and deal volume in 2023, the European health technology scene is buzzing with activity. Investors are placing their bets on startups revolutionizing treatment approaches and tackling nonclinical workflow challenges. Let's shine a spotlight on the Top 5 that shaped early-stage health-tech deals in Europe: 1️⃣ EQT Life Sciences ( & EQT Group) (Amsterdam): 197 deals 2️⃣ HTGF | High-Tech Gründerfonds (Bonn): 175 deals 3️⃣ Sofinnova Partners (Paris): 121 deals 4️⃣ Calm/Storm (Vienna): 76 deals 5️⃣ NLC Health Ventures (Amsterdam): 72 deals Explore the full list of the top 25 active VC funds in European Health-Tech through this link 👇 #HealthTech #VentureCapital #Europe #digitalhealth

As the dust settles from years of soaring valuations, our focus shifts to new expectations in 2024. At #LSIUSA24, our expert panelists will unpack the latest developments in valuation and financing, sharing forecasts and current trends that address the 2024 outlook, and provide a deep dive into how these shifts will affect both current and future investment landscapes. We’ll hear perspectives from: • Rik Vandevenne (Moderator), Managing Director, RC Capital, a Healthcare focused growth equity fund, currently investing out of its seventh fund. • Rebecca Raabe, Investment Partner, SPRIG Equity, a growth equity and late-stage venture capital firm dedicated to improving patient outcomes by partnering with best-in-class teams and technologies in the medical technology sector. • Paul McCreadie, Partner & COO Arboretum Ventures, a venture capital firm specializing in the healthcare sector investing throughout the United States, but with a preference for Midwest opportunities. • Matthew Schopp, Senior Director, Business Development, Zimmer Biomet, a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We are still accepting registrations for LSI USA ‘24 on March 18-22 in Dana Point, California. Visit our website to learn more and secure your spot: https://lnkd.in/gjgMpMBh

📣 Keeping The Cash Flow - Sustaining Momentum Through Maturation Join our panel of #MedtechLeaders as they discuss: ·  What trends or strategies do investors prioritize when assessing a medtech company's revenue outlook ·  How do successful medtech firms attract later-stage funding amid challenging economic conditions ·  Key considerations for medtech firms utilizing venture debt as a catalyst for sustained growth 🎙 Hear from: ·  David Kereiakes, Managing Partner, Windham Venture Partners ·  Darshana Zaveri, Managing Partner, Catalyst Health Ventures ·  Karthik Bolisetty, Senior Associate, Gilde Healthcare Find out more: https://lnkd.in/ey4UQiAP #LSXWorld 

Great lessons for founders who are trying to raise capital from strategics Here's a great panel from #LSIEurope23 in Barcelona (MedTech and Digital Health) + Yassaman Salas, Head of MedTech Investment Banking at Goldman Sachs + Biren Mehta at Johnson & Johnson Ventures + Nate Harrington at Philips Ventures + Kevin Rocco (founder of Biorez) at CONMED Corporation! If you're going through M&A I suggest you learn from these #powerplayers about how they think through both sides of the table You NEED to learn how to create urgency for strategics if you're trying to sell or raise. Enjoy! --- Don P.S. If you like AR/VR, you'll love my weekly newsletter (free, duh). Weekly insights to help you pitch AR/VR investors, and more. Join 5,000+ subscribers here: https://bit.ly/48ggBGB

Increasing healthcare costs, the rise of contract work, and higher employee turnover have changed the traditional ROI on employer-sponsored healthcare. Thatch is leveraging #AI to create a more flexible, personalized option for employers and employees - we are excited to be on this journey with you!

Private equity and venture capital success stories in healthcare 🏆   On Rare Disease Day, find out how the asset class supports healthcare and biotech businesses across Europe, supporting their development of novel treatments.   Filter by sector, country or type of investor ⤵️   ➡️ https://lnkd.in/ec3A-mrA   #InvestEurope #PrivateEquity #VentureCapital #BuildingBetterBusinesses #SuccessStories #RareDiseaseDay

#ICYMI: MedTech Strategist/Market Pathways's own Stephen Levin will be moderating the "Successfully Navigating Exits and Financings in Tough Times" panel discussion between Earlybird Venture Capital's Dr. Christoph Massner and LimFlow SA's Dan Rose at MedTech Europe's The MedTech Forum 2024 on Thursday, May 23 at 10:40AM-11:30AM. Despite a challenging environment for M&A and fundraising amidst an evolving EU regulatory landscape, this panel features strategics, investors and start-up CEOs who are doing deals in spite of these obstacles, and are here to share their strategies in achieving these goals. Lean more here: https://lnkd.in/ex3Y9ySx #MTF2024 #conferences #paneldiscussion #medtech #medtechindustry #medtechinnovation #regulatory

📢 AusMedtechInvest 2024 keynote spotlight: Investing in health: An angel’s journey Dr Amandeep H., founder of Australian Medical Angels, will reveal the growing role of angel investors in the domestic life science industry at AusMedtechInvest 2024, on 21 May in Adelaide. The angel investor community is becoming increasingly sophisticated and is a serious source of capital, fuelling the growth of start-ups and contributing to high growth sectors. The formation of an ecosystem of investors that have knowledge of the healthcare sector is a relatively recent development and creates more formal connections between entrepreneurs and angels. This session will cover recent developments in the angel investor community from the perspective of Australian Medical Angels and provide guidance to industry on how to navigate the angel investor landscape and assess the right partners to work with.  Register for #AusMedtechInvest2024 to hear Dr Hansra discuss the important role of wholesale investors in Australia's biotech community, what to consider when co-investing with an angel, and how both investors and innovators can achieve mutual success. Qualified investors are invited to register for a complimentary pass here: https://lnkd.in/gqp7dEdj #investment #angelinvesting #wholesaleinvestors #lifescienceinvesting

🌟 Exciting Opportunity Alert! 🌟 Join Stewart Heath, CPA, and me on July 11, 2024, at 12 PM EST for a Live Investment Webinar. We're diving deep into the potential of medical space investments with our 500 Cahaba Partners project. Take advantage of key insights that could shape your investment future! 🏥💼 👉 Register now and unlock the potential to grow your portfolio. This is an exclusive opportunity you don't want to miss. Check out the link in the comments for more details and to secure your spot. See you there! #InvestmentOpportunity #Webinar #MedicalRealEstate

Global Digital Health Investor Leaders in H1 2024 🌐💼 Over 1,600 #investors have participated in at least one funding deal in #DigitalHealth this year, with 50 making more than three investments in the first six months. This marks an increase from the previous year, when 47 investors reached this threshold, suggesting renewed confidence 📈. The top 🔝 6 investors in H1 2024 have participated in over 59 deals globally (not including accelerators and government grant programs) 🏆. General Catalyst leads the pack with 16 Digital Health deals, followed by Andreessen Horowitz and Khosla Ventures, each with 12 deals. Flare Capital Partners secured seven deals, while Insights Partners and Gaingels each made six. Download the full Galen Growth H1 2024 report (FOC) for deeper insights and analysis 📊🔍.